Fuji Pharma Co., Ltd. (4554.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥1,807 (-1.36%) as of
Key statistics
- Market cap
- 47.20B
- P/E (TTM)
- 15.06
- Forward P/E
- 11.61
- EPS (TTM)
- 119.97
- Dividend yield
- 2.67%
- 52-week range
- 1,550.00 – 2,559.00
- Beta
- 0.33
- Revenue (TTM)
- 60.1B
- Profit margin
- 4.98%
- Analyst target
- ¥2,950
- Volume
- 175.00k
About Fuji Pharma Co., Ltd.
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Tokyo, Japan
- Employees
- 1,760
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.